Frankly Speaking About Family Medicine

Pri-Med

Frankly Speaking about Family Medicine

  • 10 minutes 45 seconds
    To Treat or Not to Treat: Do Antibiotics Make a Difference with OME? - Frankly Speaking Ep 377

    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-377

    Overview: Fluid in the middle ear, or otitis media with effusion (OME), is common in children with upper respiratory infections and typically resolves without treatment. Most guidelines do not recommend antibiotics for treatment; however, they are often prescribed, and the persistence of effusion can cause a significant impact on quality of life. Join us as we discuss recent review findings on antibiotics in OME treatment and the potential impact on your practice.

    Episode resource links:

    • Mulvaney CA, Galbraith K, Webster KE, et al. Antibiotics for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2023;10(10):CD015254. Published 2023 Oct 23. doi:10.1002/14651858.CD015254.pub2
    • Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., Poe, D. S., Veling, M., Vila, P. M., Walsh, S. A., & Corrigan, M. D. (2016). Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 154(1 Suppl), S1–S41. https://doi.org/10.1177/0194599815623467

    Guest: Susan Feeney, DNP, FNP-BC, NP-C
     
    Music Credit: Richard Onorato

    23 April 2024, 1:26 pm
  • 8 minutes 15 seconds
    New Benefits Give SGLT2 Inhibitors Their Turn to Shine - Frankly Speaking Ep 376

    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-376

    Overview: While GLP-1 agents are center stage in the medical and lay press, drugs in the class of sodium-glucose cotransporter 2 inhibitors (SGLT2is) are also quite remarkable at improving a variety of health endpoints. This episode provides an overview of studies supporting the use of SGLT2is to improve patient outcomes.

    Episode resource links:

    • DM/HF:  Age Ageing 2024 Jan 2;53(1):afad254. doi: 10.1093/ageing/afad254
    • Kidney stones: JAMA Intern Med. 2024 Jan 29:e237660. doi: 10.1001/jamainternmed.2023.7660

    Guest: Susan Feeney, DNP, FNP-BC, NP-C
     
    Music Credit: Richard Onorato

    15 April 2024, 12:30 am
  • 8 minutes 9 seconds
    Breast Cancer: Increased Incidence Doesn’t Mean Increased Mortality - Frankly Speaking Ep 375

    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-375

    Overview: Listen in as we discuss trends seen in breast cancer incidence over recent decades. Despite a notable rise in its prevalence, we’ve witnessed a decline in mortality rates. This positive shift owes itself to improvements in medication and screening efforts. Explore with us the multifaceted factors shaping this evolving landscape of breast cancer diagnosis and treatment.

    Episode resource links:

    Guest: Mariyan L. Montaque, DNP, FNP-BC
     
    Music Credit: Richard Onorato

    8 April 2024, 12:30 am
  • 10 minutes 59 seconds
    Sleep Lab in Your Pocket: Smartphone Diagnostics for Sleep Apnea - Frankly Speaking Ep 374

    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-374

    Overview: This episode explores the use of data from smartphone recordings as a diagnostic tool for obstructive sleep apnea (OSA), highlighting at-home testing as a more accessible, convenient, and appropriate option for some patients. Hear how the evidence can inform your practice and improve the diagnosis and treatment of patients with OSA.

    Episode resource links:

    • Han SC, Kim D, Rhee CS, Cho SW, Le VL, Cho ES, Kim H, Yoon IY, Jang H, Hong J, Lee D, Kim JW. In-Home Smartphone-Based Prediction of Obstructive Sleep Apnea in Conjunction With Level 2 Home Polysomnography. JAMA Otolaryngol Head Neck Surg. 2024 Jan 1;150(1):22-29. doi: 10.1001/jamaoto.2023.3490. PMID: 37971771; PMCID: PMC10654929.
    • OSA and CV disease in adults, UpToDate
    • Home sleep apnea testing for adults, UpToDate

    Guest: Jillian Joseph, MPAS, PA-C
     
    Music Credit: Richard Onorato

    1 April 2024, 12:30 am
  • 11 minutes 13 seconds
    Type 2 Diabetes Mellitus: Can Lifestyle Reverse It? - Frankly Speaking Ep 373

    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-373

    Overview: In this episode, we review the effectiveness of intensive lifestyle intervention for type 2 diabetes mellitus (T2DM) remission. We unpack study findings on total diet replacement and consider its potential for improving weight loss and maintenance in patients. Tune in to enrich your clinical toolkit, empowering you to optimize patient outcomes and enhance quality of life.

    Episode resource links:

    • Hocking, S. L., Markovic, T. P., Lee, C. M. Y., Picone, T. J., Gudorf, K. E., & Colagiuri, S. (2024). Intensive Lifestyle Intervention for Remission of Early Type 2 Diabetes in Primary Care in Australia: DiRECT-Aus. Diabetes care, 47(1), 66–70. https://doi.org/10.2337/dc23-0781

       

    • Centers for Disease Control:  Diabetes Care for Providers: https://www.cdc.gov/diabetes/professional-info/index.html

       

    • Optifast USA: https://www.optifast.com/

       

    • Pattinson, A. L., Seimon, R. V., Harper, C., Nassar, N., Grech, A., Santoso, E. A., Franklin, J., Inan-Eroglu, E., Gibson, A. A., & Sainsbury, A. (2021). Diet Quality following Total Meal Replacement Compared with Food-Based Weight-Loss Diets in Postmenopausal Women with Obesity: A Secondary Analysis of the TEMPO Diet Trial. The Journal of nutrition, 151(11), 3299–3312. https://doi.org/10.1093/jn/nxab311

    Guest: Jill M. Terrien, PhD, ANP-BC 
     
    Music Credit: Richard Onorato

    25 March 2024, 12:30 am
  • 10 minutes 30 seconds
    Chocolate—Get the Lead Out! - Frankly Speaking Ep 372

    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-372

    Overview: Listen in as we unwrap Consumer Reports’ findings on heavy metals found in commonly consumed chocolate products. Our discussion looks into concerns about high levels of metals like lead and cadmium in these treats and offers advice on how to counsel your patients for worry-free chocolate enjoyment. 

    Episode resource links:

    Guest: Robert A. Baldor, MD, FAAFP
     
    Music Credit: Richard Onorato

    18 March 2024, 12:30 am
  • 7 minutes 39 seconds
    Beta-Blockers Post-Myocardial Infarction: Are They Still Needed? - Frankly Speaking Ep 371

    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-371

    Overview: Beta-blockers have traditionally been used indefinitely after a myocardial infarction (MI), but this is now only recommended for a subset of patients. Listen in as faculty review new recommendations for managing patients with chronic cardiac disease, including how to determine which patients are good candidates for beta-blocker therapy and for how long.

    Episode resource links:

    • Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2023 Sep 26;148(13):e148] [published correction appears in Circulation. 2023 Dec 5;148(23):e186]. Circulation. 2023;148(9):e9-e119. 
    • Joo SJ. Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it. Acute Crit Care. 2023;38(3):251-260. 

    Guest: Alan M. Ehrlich, MD, FAAFP
     
    Music Credit: Richard Onorato

    11 March 2024, 12:30 am
  • 11 minutes 8 seconds
    Low Back Pain—More Evidence for the Effectiveness of Nonnarcotic Modalities - Frankly Speaking Ep 370

    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-370

    Overview: Low back pain is one of the most common symptoms presenting in primary care. Listen in as we analyze the results of a recent systematic review supporting the use of a variety of effective nonnarcotic treatments for this condition. Gain evidence-based insights to help you choose the most informed option for managing low back pain.

    Episode resource links:

    • Gianola S, Bargeri S, Del Castillo G, et al. Br J Sports Med 2022;56:41–50. doi.org/ 10. 1136/ bjsports- 2020- 103596).

    Guest: Robert A. Baldor, MD, FAAFP
     
    Music Credit: Richard Onorato

    4 March 2024, 12:30 am
  • 9 minutes 28 seconds
    Be a Flamingo: 1-Legged Stance Test Predicts Risks - Frankly Speaking Ep 369

    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-369

    Overview: Uncover a simple, 10-second intervention—the 1-legged stance test—for predicting the risk of falling in adults. Join us as we discuss how this swift assessment can help identify patients who are prone to falls, fractures, and increased mortality. This episode brings you a practical tool to enhance patient assessments and tailor interventions, contributing to a more proactive and personalized approach to care.

    Episode resource links:

    • JAMA. 2023;329(18):1605-1607. doi:10.1001/jama.2023.3054
    • Br J Sports Med. 2022;56:975–980.
    • Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1049-1056. doi: 10.1002/pds.5201
    • PLoS Med 18(11): e1003821. https://doi.org/10.1371/journal.pmed.1003821

    Guest: Jillian Joseph, MPAS, PA-C
     
    Music Credit: Richard Onorato

    26 February 2024, 12:30 am
  • 8 minutes 17 seconds
    Data-Driven Perspectives on Prescriptive Authority and the Quality Quandary - Frankly Speaking Ep 368

    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-368

    Overview: In this insightful episode, we explore compelling data comparing inappropriate prescribing practices among physicians and nonphysician prescribers. This discussion covers the nuances and restrictive scope of prescribing authority and aims to take an evidence-based approach to encouraging collaboration between clinicians and expanding patients’ access to care.

    Episode resource links:

    Guest: Jill M. Terrien PhD, ANP-BC 
     
    Music Credit: Richard Onorato

    19 February 2024, 12:30 am
  • 12 minutes 37 seconds
    The Portfolio Diet—Another Approach to Eating Healthy? - Frankly Speaking Ep 367

    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-367

    Overview: Join us for a look at the Portfolio Diet, a plant-based approach with potential to improve cardiovascular outcomes. We’ll take you through the details of this regimen and what the evidence says about its effect on the risks of cardiovascular diseases. Stay informed on the latest research and feel prepared to answer your patients’ questions about the Portfolio Diet.

    Episode resource links:

    • Circulation. 2023;148:00–00. DOI: 10.1161/CIRCULATIONAHA.123.065551

    Guest: Robert A. Baldor, MD, FAAFP
     
    Music Credit: Richard Onorato

    12 February 2024, 12:30 am
  • More Episodes? Get the App
© MoonFM 2024. All rights reserved.